Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous fibrinogen for bleeding prevention during total hip arthroplasty
IRCT20120910010800N3Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- May 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Bleeding associated with total hip arthroplasty comparing Fibrinogen with Placebo (2 arms). Primary endpoints: Bleeding during surgery and Postoperative bleeding. Started May 2022; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
Bleeding associated with total hip arthroplasty
Beyond the preview
Go deeper on IRCT20120910010800N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120910010800N3.